Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesIntegrated care and optimal management of pulmonary arterial hypertension
Journal of Multidisciplinary Healthcare, 08/27/09
Strange G et al. – This article reviews the evidence for screening and diagnosis of susceptible patient groups and discusses treatment selection and recommendations based on data available from randomized controlled trials. In addition, due to the complexity of the diagnostic evaluation required and the treatment options available, this review mandates for a multidisciplinary approach to the management of PAH. The authors discuss the roles and organizational structure of a specialized PAH center in Perth, Western Australia to highlight these issues.
Related Articles
New finding could lead to cure of pulmonary arterial hypertension
Internet Source, 10/26/09
Relevance Score: 82%
Inhibitory Effects of Simvastatin on Platelet-derived Growth Factor Signaling in Pulmonary Artery Smooth Muscle Cells from Patients with Idiopathic Pulmonary Arterial Hypertension
Journal of Cardiovascular Pharmacology, 10/12/09
Relevance Score: 81%
Gilead Sciences Announces Plans for Phase IV Clinical Trial Evaluating First-Line Combination Therapy Versus Monotherapy in Pulmonary Arterial Hypertension
Gilead, 11/03/09
Relevance Score: 80%
Sequence Variants in BMPR2 and Genes Involved in the Serotonin and Nitric Oxide Pathways in Idiopathic Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Relation to Clinical Parameters and Comparison with Left Heart Disease
Respiration, 10/20/09
Relevance Score: 80%
Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
Journal of Rheumatology, 10/15/09
Relevance Score: 80%
Today in CV/Thromboembolic...keeping you current
Receive free subspecialty "5-minute updates" via email
Tadalafil for the treatment of pulmonary arterial hypertension
Expert Opinion in Pharmacotherapy, 12/14/09
Bosentan for chronic thromboembolic pulmonary hypertension
Expert Review of Cardiovascular Therapy , 12/14/09
Abnormal troponin I levels in acute pulmonary embolism without abnormal concentrations of D-dimer at admission
International Journal of Cardiology, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor